An Act amending the act of October 24, 2018 (P.L.719, No.112), known as the Patient Test Result Information Act, further providing for definitions; providing for prostate-specific antigen test results; and further providing for duties of Department of Health.

This bill amends Pennsylvania's Patient Test Result Information Act to require laboratories to directly notify patients when their prostate-specific antigen blood tests show abnormal results. Under the new rules, labs must send a notice within five days that includes a plain-language summary of the findings, the name of the doctor who ordered the test, and instructions on how to get the full report. The Department of Health is tasked with overseeing compliance with these notification requirements and creating a publicly available list of age-specific normal and abnormal test levels. While the full results are still sent to the ordering doctor, the law ensures patients receive immediate awareness of potential issues and are encouraged to contact their healthcare provider promptly.